Beattie D T, Cunnane T C, Muir T C
Br J Pharmacol. 1986 Sep;89(1):235-44. doi: 10.1111/j.1476-5381.1986.tb11140.x.
The effects of the Ca2+ channel antagonists amlodipine, cobalt, diltiazem, nifedipine and verapamil and the local anaesthetic lignocaine were investigated on action potential conduction in and on evoked transmitter release from sympathetic nerves in the guinea-pig isolated vas deferens. Transmitter release was investigated by measurement of evoked (trains of pulses at 1 and 2 Hz, 0.1-0.5 ms supramaximal voltage) excitatory junction potentials (e.j.ps) using microelectrodes; tension was recorded simultaneously; tritium [3H] overflow from vasa preincubated (37 degrees C, 30 min) in Krebs solution containing either [3H]-noradrenaline (NA, 25 microCi ml-1, 2 X 10(-6) M NA) or [3H]-adenosine (50 microCi ml-1, 1 X 10(-6) M adenosine). Amlodipine (0.5-2 X 10(-4) M), verapamil (0.5-2 X 10(-4) M), diltiazem (1-8 X 10(-4) M), lignocaine (0.1-2 X 10(-3) M) and cobalt (2-6 X 10(-2) M) in descending order of potency, but not nifedipine (1-5 X 10(-3) M), increased the latency and inhibited, then abolished, the amplitude and number of action potentials in a concentration-dependent manner. Amlodipine (0.5-1 X 10(-4) M), verapamil (1-2 X 10(-4) M), diltiazem (1-5 X 10(-4) M) and cobalt (1 X 10(-3) M), in descending order of potency, but not nifedipine (5 X 10(-4) M), inhibited then abolished evoked e.j.ps in a concentration-dependent manner. Cobalt inhibited e.j.ps at a lower concentration than that (2-6 X 10(-2) M) required to block action potential conduction. In unstimulated tissues, the resting [3H] overflow following preincubation with [3H]-NA consisted largely of 4-hydroxy 3-methoxymandelic acid (VMA), 4-hydroxy 3-methoxy phenylglycol (MOPEG), 3,4 dihydroxyphenylglycol (DOPEG) and NA; stimulated tissues (300 pulses at 20 Hz, 0.5 ms supramaximal voltage) released mainly NA. Verapamil (0.1-1 X 10(-4) M), amlodipine (0.05-1 X 10(-4) M) and nifedipine (1-5 X 10(-4) M), but not cobalt (2 X 10(-3) M), increased, significantly, the resting overflow of 3H comprising mainly DOPEG. Cobalt (2 X 10(-3) M) inhibited, significantly, the stimulation-evoked overflow of 3H. Verapamil (1 X 10(-4) M) had little effect on the resting overflow of 3H following preincubation with [3H]-adenosine. Diltiazem (5 X 10(-4) M) and cobalt (2 X 10(-3) M) both inhibited evoked 3H overflow. Nifedipine (5 X 10(-4) M) was ineffective. 6 The effectiveness of Ca2+ channel antagonists at pre- and postjunctional sites differ; the results are discussed in terms of the selectivity of these drugs for each site and their differential effects on transmitter release.
研究了钙离子通道拮抗剂氨氯地平、钴、地尔硫䓬、硝苯地平和维拉帕米以及局部麻醉药利多卡因对豚鼠离体输精管交感神经动作电位传导和诱发递质释放的影响。通过使用微电极测量诱发的(1和2Hz的脉冲串,0.1 - 0.5ms超最大电压)兴奋性接头电位(e.j.ps)来研究递质释放;同时记录张力;测量预先在含有[3H]-去甲肾上腺素(NA,25μCi/ml,2×10(-6)M NA)或[3H]-腺苷(50μCi/ml,1×10(-6)M腺苷)的 Krebs 溶液中孵育(37℃,30分钟)的输精管中氚[3H]的溢出。氨氯地平(0.5 - 2×10(-4)M)、维拉帕米(0.5 - 2×10(-4)M)、地尔硫䓬(1 - 8×10(-4)M)、利多卡因(0.1 - 2×10(-3)M)和钴(2 - 6×10(-2)M),按效力递减顺序,但硝苯地平(1 - 5×10(-3)M)除外,以浓度依赖性方式增加动作电位的潜伏期,并抑制然后消除动作电位的幅度和数量。氨氯地平(0.5 - 1×10(-4)M)、维拉帕米(1 - 2×10(-4)M)、地尔硫䓬(1 - 5×10(-4)M)和钴(1×10(-3)M),按效力递减顺序,但硝苯地平(5×10(-4)M)除外,以浓度依赖性方式抑制然后消除诱发的 e.j.ps。钴抑制 e.j.ps 所需的浓度低于阻断动作电位传导所需的浓度(2 - 6×10(-2)M)。在未刺激的组织中,用[3H]-NA 预孵育后的静息[3H]溢出主要由 4 - 羟基 - 3 - 甲氧基扁桃酸(VMA)、4 - 羟基 - 3 - 甲氧基苯乙二醇(MOPEG)、3,4 - 二羟基苯乙二醇(DOPEG)和 NA 组成;刺激的组织(20Hz 下 300 个脉冲,0.5ms 超最大电压)主要释放 NA。维拉帕米(0.1 - 1×10(-4)M)、氨氯地平(0.05 - 1×10(-4)M)和硝苯地平(1 - 5×10(-4)M),但钴(2×10(-3)M)除外,显著增加主要由 DOPEG 组成的 3H 的静息溢出。钴(2×10(-3)M)显著抑制刺激诱发的 3H 溢出。维拉帕米(1×10(-4)M)对用[3H]-腺苷预孵育后的 3H 静息溢出影响很小。地尔硫䓬(5×10(-4)M)和钴(2×10(-3)M)均抑制诱发的 3H 溢出。硝苯地平(5×10(-4)M)无效。6 钙离子通道拮抗剂在节前和节后位点处的效力不同;根据这些药物对每个位点的选择性及其对递质释放的不同影响对结果进行了讨论。